设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
SpringerLink电子期刊(1)
Elsevier电子期刊(4)
在“
Elsevier电子期刊
”中,
命中:
4
条,耗时:小于0.01 秒
在所有数据库中总计命中:
5
条
1.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial
作者:
Prof Christoph Zielinski
;
MD
a
;
christoph.zielinski@meduniwien.ac.at" class="auth_mail" title="E-mail the corresponding author
;
Prof Istvá
;
n Lá
;
ng
;
MD
b
;
Prof Moshe Inbar
;
MD
c
;
Prof Zsuzsanna Kahá
n ;
MD
d
;
Prof Richard Greil
;
MD
e
;
Prof Semir Beslija
;
MD
f
;
Salomon M Stemmer
;
MD
g
;
Zanete Zvirbule
;
MD
h
;
Gü
;
nther G Steger
;
MD
a
;
Prof Bohuslav Melichar
;
MD
i
;
Tadeusz Pienkowski
;
MD
j
;
Daniela Sirbu
;
MD
k
;
Prof Lubo&scaron
;
Petruzelka
;
MD
l
;
Alexandru Eniu
;
MD
m
;
Bella Nisenbaum
;
MD
n
;
Prof Magdalena Dank
;
MD
o
;
Prof Rodica Anghel
;
MD
p
;
Diethelm
Messinger
;
MSc
q
;
Thomas Brodowicz
;
MD
a
;
for the TURANDOT investigators
&dagger
;
刊名:The Lancet Oncology
出版年:2016
2.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial
作者:
Prof Istvan Lang
;
MD
a
;
Thomas Brodowicz
;
MD
b
;
Larisa Ryvo
;
MD
c
;
Prof Zsuzsanna Kahan
;
MD
d
;
Prof Richard Greil
;
MD
e
;
Semir Beslija
;
MD
f
;
Salomon M Stemmer
;
MD
g
;
Bella Kaufman
;
MD
h
;
Zanete Zvirbule
;
MD
i
;
Gü
;
nther G Steger
;
MD
b
;
Prof Bohuslav Melichar
;
MD
j
;
Tadeusz Pienkowski
;
MD
k
;
Daniela Sirbu
;
MD
l
;
Diethelm
Messinger
;
MSc
m
;
Prof Christoph Zielinski
;
MD
b
;
christoph.zielinski@meduniwien.ac.at
;
on behalf of the Central European Cooperative Oncology Group
&dagger
;
刊名:Lancet Oncology
出版年:2013
3.
Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin
作者:
Patrick Marcellin
1
;
patrick.marcellin@bjn.aphp.fr
;
Nancy Reau
2
;
Peter Ferenci
3
;
Stephanos Hadziyannis
4
;
Diethelm
Messinger
5
;
Fernando Tatsch
6
;
Donald Jensen
7
关键词:
RVR
;
rapid virological response
;
SVR
;
sustained virological response
;
HCV
;
hepatitis C virus
;
EVR
;
early virological response
;
PCR
;
polymerase chain reaction
;
cEVR
;
complete early virological response
刊名:Journal of Hepatology
出版年:2012
4.
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
作者:
Michael W. Fried
1
;
mfried@med.unc.edu"" rel=""nofollow
;
Stephanos J. Hadziyannis
2
;
Mitchell L. Shiffman
3
;
Diethelm
Messinger
4
;
Stefan Zeuzem
5
刊名:Journal of Hepatology
出版年:2011
1
按检索点细分(4)
作者(4)
按出版年细分(4)
2016年(1)
2013年(1)
2012年(1)
2011年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.